Download presentation
Presentation is loading. Please wait.
Published byBørge Eskildsen Modified over 5 years ago
1
Patrick: An Introduction to Medicinal Chemistry 6e
Chapter 21 ANTICANCER AGENTS ALKYLATING AND METALLATING AGENTS Modified
2
Alkylating agents Notes Contain highly electrophilic groups
Form covalent bonds to nucleophilic groups in DNA (e.g. 7-N of guanine) Prevent replication and transcription Useful anti-tumour agents Toxic side effects (e.g. alkylation of proteins) Used as anticancer agents Can cause interstrand and intrastrand crosslinking if two electrophilic groups are present Alkylation of nucleic acid bases can result in miscoding
3
Alkylating agents Crosslinking Intrastrand crosslinking
Interstrand crosslinking
4
Alkylating agents Nucleophilic groups on nucleic acid bases
Cytosine Guanine Adenine Nucleophilic groups Replaced captions indicating nucleophilic groups and arrows
5
Alkylating agents Miscoding resulting from alkylated nucleic acid bases N-Alkylated guanine Thymine Cytosine Guanine Guanine prefers keto tautomer Normal base pairing to cytosine Alkylated guanine prefers enol tautomer Abnormal base pairing to thymine Modified
6
Alkylating agents Chlormethine Notes Used medicinally in 1942
Example of a nitrogen mustard Causes intrastrand and interstrand crosslinking Prevents replication Monalkylation of guanine also possible Analogues with better properties have been prepared
7
Alkylating agents Chlormethine Mechanism of action Crosslinked DNA
Mechlorethamine Aziridine ion Modified mechlorethamine redrawn Crosslinked DNA
8
Alkylating agents Chlormethine analogues
Aromatic ring is electron withdrawing Lowers nucleophilic strength of nitrogen Less reactive alkylating agent Less side reactions and less toxic Melphalan Aromatic ring is present Less reactive alkylating agent Mimics phenylalanine Transported into cells by transport proteins All structures redrawn Uracil mustard Uracil ring is electron withdrawing Less reactive alkylating agent Mimics a nucleic acid base Concentrated in fast growing cells
9
Alkylating agents Chlormethine analogues
Estramustine Urethane group is electron withdrawing Lowers nucleophilic strength of nitrogen Alkylating group is attached to estradiol Steroid is hydrophobic Capable of crossing cell membranes Urethane
10
Alkylating agents Cyclophosphamide Notes
Cytochrome P450 enzymes Cyclophosphamide R = CH2CH2Cl Alkylating agent Acrolein Modified Third and fourth structures redrawn Notes Cyclophosphamide is the most commonly used alkylating agent Non-toxic prodrug Orally active Acrolein is associated with toxicity
11
(carbamoylating agent)
Alkylating agents Nitrosoureas Lomustine Carmustine Notes Decompose in the body to form an alkylating agent and a carbamoylating agent Top structures redrawn Isocyanate (carbamoylating agent) + Alkylating agent
12
Alkylating agents Nitrosoureas Notes
DNA Akylation Cross linking Isocyanate Protein-Lys-NH2 Carbamoylation Protein-Lys-NH Notes Alkylating agent causes interstrand crosslinking Cross linking between G-G or G-C Carbamoylating agent reacts with lysine residues on proteins May inactivate DNA repair enzymes Diagrams redrawn
13
Alkylating agents Busulfan Notes
Synthetic agent used as an anticancer agent Causes interstrand crosslinking -MeSO3- Modified Busulfan redrawn -MeSO3-
14
Alkylating agents Dacarbazine
Prodrug activated by demethylation in liver Decomposes to form a methyldiazonium ion Alkylates guanine groups Cyt P-450 Liver -CH2O N CH3
15
Alkylating agents Mitomycin C
Modified Prodrug activated in the body to form an alkylating agent One of the most toxic anticancer drugs in clinical use
16
-MeOH Reduction Ring opening -H + Alkylating agent Modified all structures redrawn aprt from last one -CO2 -NH3 Crosslinked DNA
17
Alkylating agents CC1065 Naturally occurring agent
Binds to minor groove of DNA Alkylates adenine bases 1000 times more active than cisplatin in vitro
18
Alkylating agents Adozelesin Simplified synthetic analogue of CC 1065
Possible use in antibody-drug conjugates
19
Metallating agents Cisplatin
Neutral inactive molecule acting as a prodrug Platinum covalently linked to chloro substituents Ammonia molecules act as ligands Activated in cells with low chloride ion concentration Chloro substituents are replaced with neutral water ligands Produces positively charged species that react with DNA DNA + H2O Cisplatin 2+ Modified Lower Diagram redrawn
20
Metallating agents Cisplatin
Binds to DNA in regions rich in guanine units Intrastrand links are formed rather than interstrand Causes localised unwinding of the DNA double helix Inhibits transcription
21
Metallating agents Cisplatin analogues Carboplatin Satraplatin (JM216)
Less side effects Satraplatin (JM216) First orally active analogue Oxaliplatin Approved in 1999 Modified Satraplatin redrawn
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.